ISPO

multidrug resistance

Bcl-2 plays a key role instead of mdr1 in the resistance to hexadecylphosphocholine in human epidermoid tumour cell line KB

D Fu PhD, Y Wang MD

Expression of multidrug resistance transporters in polycyclic aromatic hydrocarbon-resistant rat liver cells

L Payen, A Courtois, S Langouët, A Guillouzo, O Fardel

Proteomics and mechanisms of chemoresistance in cancer cells in vitro

P Sinha MD PhD , H Lage PhD , S Kohl , JE Celis PhD , M Schnölzer PhD , D Schadendorf MD PhD

The MTS assay as an indicator of chemosensitivity / resistance in malignant gynaecological tumours

SA O'Toole MSc, BL Sheppard PhD, JB Bonnar MD, E McGuinness MD, N Gleeson MD

Possible involvement of the changes of PKC-alpha-expression in leptin and glucose-induced cell proliferation in drug sensitive human beast cancer cells (MCF7) not in multi-drug resistant cells (MCF7/ADR)

M Okumura MD , M Yamamoto MD , H Sakuma MD , T Kojima MD , T Maruyama MD , K Yasuda MD , DR Cooper PhD

Modulation of cisplatin cytotoxicity and cisplatin-induced DNA cross-links in HepG2 cells by regulation of glutathione-related mechanisms

K Zhang PhD , M Chew BSc , EB Yang PhD , KP Wong PhD , P Mack PhD

Caveolin expression in drug-sensitive lung cancer cells: effect of chemotherapeutic drugs

J Couet PhD, MM Belanger BSc, E Roussel BSc

Corticoids in lymphoid malignancies therapy : studies with an in vitro model of specific resistance

V Genty PhD , G Dine MD PhD